Our Technology
The ImmuneFx Platform
The purpose of a cancer immunotherapy is to initiate and focus the enormous power of the immune system on tumor cells. Our technology does this in the most effective manner possible. In fact, IFx-Hu2.0 primes and educates the immune system to destroy tumor cells throughout the body without harming healthy cells and tissues. It does this by expressing a bacterial antigen on the surface of a patient’s own tumor cells.
A Unique Approach
Unlike other cancer immunotherapies, our technology combines cell AND gene therapy to promote cross-presentation and priming.
A Personalized Off-the-shelf Product
While most immunotherapies focus on a single aspect of cancer immunity, our technology modulates the tumor microenvironment in multiple ways by priming, generating, guiding and augmenting both innate and adaptive immune pathways